Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Bone morphogenetic protein receptor type-1A [198-525] | ||
Ligand | BDBM451778 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ADPGlo Assay | ||
IC50 | 1400±n/a nM | ||
Citation | Arista, L; Babu, S; Bian, J; Cui, K; Dillon, MP; Lattmann, R; Li, J; Liao, L; Lizos, D; Ramos, R; Stiefl, NJ; Ullrich, T; Usselmann, P; Wang, X; Waykole, LM; Weiler, S; Zhang, Y; Zhou, Y; Zhu, T Aminopyridine derivatives and their use as selective ALK-2 inhibitors US Patent US10947218 Publication Date 3/16/2021 | ||
More Info.: | Get all data from this article, Assay Method | ||
Bone morphogenetic protein receptor type-1A [198-525] | |||
Name: | Bone morphogenetic protein receptor type-1A [198-525] | ||
Synonyms: | ACVRLK3 | ALK3 | Activin receptor-like kinase 3 (ALK3) (aa 198-525) | Activin receptor-like kinase 3 (ALK3)(198-525) | BMPR1A | BMR1A_HUMAN | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 37140.17 | ||
Organism: | Homo sapiens (Human) | ||
Description: | aa 198-525 | ||
Residue: | 328 | ||
Sequence: |
| ||
BDBM451778 | |||
n/a | |||
Name | BDBM451778 | ||
Synonyms: | US10710980, Example 10 | US10947218, Example 10 | ||
Type | Small organic molecule | ||
Emp. Form. | C29H39N5O3 | ||
Mol. Mass. | 505.6517 | ||
SMILES | Nc1ncc(cc1C(=O)N[C@H]1CC[C@H](O)CC1)-c1ccc(cc1)[C@@]12C[C@@H]1CN(CCN1CCOCC1)C2 |r,wU:23.25,10.10,wD:25.27,13.14,(-5.42,6.3,;-4.09,5.53,;-2.75,6.3,;-1.42,5.53,;-1.42,3.99,;-2.75,3.22,;-4.09,3.99,;-5.42,3.22,;-6.76,3.99,;-5.42,1.68,;-6.76,.91,;-6.89,-.63,;-8.29,-1.28,;-9.55,-.39,;-10.75,-1.04,;-9.41,1.14,;-8.02,1.79,;-.09,3.22,;-.09,1.68,;1.25,.91,;2.58,1.68,;2.58,3.22,;1.25,3.99,;3.91,.91,;4.07,2.44,;5.32,1.53,;6.35,.39,;5.58,-.94,;6.21,-2.35,;7.74,-2.34,;8.44,-3.63,;7.67,-4.96,;8.44,-6.3,;9.98,-6.3,;10.75,-4.96,;9.98,-3.63,;4.07,-.62,)| | ||
Structure |